litlas
ログインアカウント作成

Patrick Vermersch

1991–2025 年に発表

131
論文数
18,142
被引用数
71
h 指数
124
i10 指数

被引用数

Patrick Vermersch の年別被引用数1949 年: 被引用 1 件1975 年: 被引用 1 件1987 年: 被引用 1 件1990 年: 被引用 2 件1992 年: 被引用 3 件1994 年: 被引用 2 件1995 年: 被引用 9 件1996 年: 被引用 9 件1997 年: 被引用 29 件1998 年: 被引用 39 件1999 年: 被引用 38 件2000 年: 被引用 38 件2001 年: 被引用 40 件2002 年: 被引用 63 件2003 年: 被引用 40 件2004 年: 被引用 57 件2005 年: 被引用 41 件2006 年: 被引用 88 件2007 年: 被引用 111 件2008 年: 被引用 102 件2009 年: 被引用 107 件2010 年: 被引用 122 件2011 年: 被引用 135 件2012 年: 被引用 138 件2013 年: 被引用 100 件2014 年: 被引用 106 件2015 年: 被引用 114 件2016 年: 被引用 116 件2017 年: 被引用 120 件2018 年: 被引用 163 件2019 年: 被引用 527 件2020 年: 被引用 642 件2021 年: 被引用 549 件2022 年: 被引用 515 件2023 年: 被引用 342 件2024 年: 被引用 653 件2025 年: 被引用 379 件2026 年: 被引用 10 件1950〜1974 年は被引用が無いため表示していません1976〜1986 年は被引用が無いため表示していません1988〜1989 年は被引用が無いため表示していません1991 年は被引用が無いため表示していません1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,464 件、この内訳の 17.6%イギリス: 引用元論文 754 件、この内訳の 9.1%ドイツ: 引用元論文 657 件、この内訳の 7.9%フランス: 引用元論文 603 件、この内訳の 7.2%イタリア: 引用元論文 587 件、この内訳の 7%オランダ: 引用元論文 383 件、この内訳の 4.6%カナダ: 引用元論文 377 件、この内訳の 4.5%スペイン: 引用元論文 324 件、この内訳の 3.9%スイス: 引用元論文 284 件、この内訳の 3.4%中国: 引用元論文 262 件、この内訳の 3.1%オーストラリア: 引用元論文 241 件、この内訳の 2.9%スウェーデン: 引用元論文 211 件、この内訳の 2.5%
0%17.6%その他 26.3%

機関

分野

  • Medicine80.8%
  • Neuroscience8.1%
  • Biochemistry, Genetics and Molecular Biology6.5%
  • Immunology and Microbiology1.8%
  • Computer Science0.7%
  • Engineering0.5%
  • その他1.6%

トピック

  • Multiple Sclerosis Research Studies14.9%
  • Peripheral Neuropathies and Disorders5.8%
  • Dementia and Cognitive Impairment Research5.8%
  • Alzheimer's disease research and treatments5.1%
  • Polyomavirus and related diseases2.4%
  • Systemic Lupus Erythematosus Research2.1%
  • その他63.9%

共著者

全論文

検索で開く
  1. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

    著者: Ludwig Kappos, Amit Bar‐Or, Bruce Cree, Robert J. Fox, Gavin Giovannoni, Ralf Gold, Patrick Vermersch, Douglas L. Arnold, Sophie Arnould, Tatiana Scherz, Christian Wolf, Erik Wallström, Frank Dahlke, Anat Achiron, Lutz Achtnichts, Kadriye Ağan, Gülşen Akman‐Demir, Alison Allen, Jack P. Antel, Alfredo Rodríguez Antigüedad, Michelle Apperson, Angela Applebee, Guillermo Izquierdo Ayuso, Masayuki Baba, Ovidiu Băjenaru, Rodica Balasa, Belgin Petek Balcı, Michael Barnett, Ann Bass, V. Becker, Mihaela Bejinariu, Florian Then Bergh, Arnfin Bergmann, Evanthia Bernitsas, Achim Berthele, Virender Bhan, Felix Bischof, Randall J. Bjork, Gregg Blevins, Matthias Boehringer, Thomas Boerner, Robert Bonek, James D. Bowen, Allen C. Bowling, Alexey Boyко, Cavit Boz, Vera Bracknies, Stefan Braune, Vincenzo Brescia Morra, Bruno Brochet, Waldemar Brola, Paul Brownstone, M Brozman, Donald Brunet, Ioan Buraga, Margaret Burnett, Mathias Buttmann, Helmut Butzkueven, Jonathan Cahill, Jonathan Calkwood, William Camu, Mark Cascione, G. Castelnovo, Diego Centonze, João Cerqueira, Andrew Chan, Andrea Cimprichová, Stanley Cohan, Giancarlo Comi, Jill Ker Conway, Joanna A. Cooper, John R. Corboy, Jorge Correale, Brian Costell, David A. Cottrell, Patricia K. Coyle, Matthew Craner, Liying Cui, Luı́s Cunha, Anna Członkowska, Ana Silva, Joao de, de Sèze, Marc Debouverie, Jan Debruyne, D. Decoo, G. Defer, Tobias Derfuß, Norma Deri, Bhupesh Dihenia, Péter Diószeghy, Vladimír Donáth, Bénédicte Dubois, Martin Duddy, Pierre Duquette, Gilles Edan, Hüsnü Efendi, Stanton B. Elias, Peter Emrich, Bonaventura Casanova Estruch ほか 228 名 - The Lancet 2018 被引用: 925

  2. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

    著者: Philip Scheltens, Didier Leys, Frederik Barkhof, D. Huglo, H. C. Weinstein, Patrick Vermersch, Michaël Kuiper, M Steinling, Erik Ch. Wolters, Jaap Valk - Journal of Neurology Neurosurgery & Psychiatry 1992 被引用: 1,776

  3. A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

    著者: Gavin Giovannoni, Gıancarlo Comı, Stuart D. Cook, Kottil Rammohan, Peter Rieckmann, Per Soelberg Sørensen, Patrick Vermersch, Peter Chang, Anthony Hamlett, Bruno Musch, Steven J. Greenberg - New England Journal of Medicine 2010 被引用: 1,007

  4. Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

    著者: Daniel S. Reich, Douglas L. Arnold, Patrick Vermersch, Amit Bar‐Or, Robert J. Fox, André Palma da Cunha Matta, Timothy J. Turner, Erik Wallström, Xinyan Zhang, Miroslav Mareš, Ф. А. Хабиров, Anthony Traboulsee, François Grand’Maison, François Jacques, Anthony Traboulsee, Michaela Týblová, Eva Meluzínová, Radek Ampapa, Martin Vališ, Pavel Hradilke, Miroslav Mareš, Pavel Štourač, Katrin Gross‐Paju, David Laplaud, Guillaume Mathey, Bernard M.J. Uitdehaag, Evgeny Evdoshenkoo, Е. В. Попова, Maria Zakharova, N. А. Totolyan, И. В. Литвиненко, Ф. А. Хабиров, С А Сиверцева, Viera Hančinová, Ema Kantorová, María Luisa Martínez Ginés, Xavier Montalbán, Sara Eichau Maduano, José Meca-Lallana, Lluís Ramió‐Torrentà, Tetyanna Nehrych, V.M. Pashkovskyy, Sergii Moskovko, O. I. Kalbus, Marta Khavunka, Volodymyr Pryshchepa, Alla Goloborodko, Daniel Wynn, William Honeycutt, Sibyl Wray, Brian Steingo, Christopher LaGanke, DeRen Huang, John M. Hemphill, Lawrence Goldstick, Derrick Robertson - The Lancet Neurology 2021 被引用: 192

  5. Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

    著者: Bruno Dubois, Jesús López‐Arrieta, Stanley Lipschitz, Triantafyllos Doskas, Luiza Spiru, Svitlana Moroz, Olena Venger, Patrick Vermersch, Alain Moussy, Colin D. Mansfield, Olivier Hermine, Magda Tsolaki, for the AB09004 Study Group Investigators - Alzheimer s Research & Therapy 2023 被引用: 94

  6. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

    著者: Raju Kapoor, Pei‐Ran Ho, Nolan Campbell, Ih Chang, Aaron Deykin, Fiona Forrestal, Nisha Lucas, Bei Yu, Douglas L. Arnold, Mark S. Freedman, Myla Goldman, Hans-Peter Hartung, Eva Havrdová, Douglas Jeffery, A Miller, Finn Sellebjerg, Diego Cadavid, Dan Mikol, Deborah Steiner, E Bartholomé, Marie D’hooghe, Massimo Pandolfo, Bart Van Wijmeersch, Virender Bhan, Gregg Blevins, Donald Brunet, Virginia Devonshire, Pierre Duquette, Mark S. Freedman, François Grand’Maison, François Jacques, Yves Lapierre, Liesly Lee, Sarah A. Morrow, Michael Yeung, Michal Dufek, Eva Havrdová, Petr Kaňovský, Ivana Štětkářová, Marika Talábová, Jette Lautrup Frederiksen, Matthias Kant, Thor Petersen, Mads Ravnborg, Finn Sellebjerg, Laura Airas, Irina Elovaara, Juha-Pekka Erälinna, Taneli Sarasoja, Abdullatif Al Khedr, David Brassat, Bruno Brochet, William Camu, Marc Debouverie, David Laplaud, Christine Lebrun‐Frénay, Jean Pelletier, Patrick Vermersch, Sandra Vukusi, Karl Baum, Achim Berthele, Juergen Faiss, Peter Flachenecker, Reinhard Hohlfeld, Markus Krumbholz, Christoph Lassek, Mathias Maeurer, Sven G. Meuth, Tjalf Ziemssen, Orla Hardiman, Christopher McGuigan, Anat Achiron, Dimitrios Karussis, Roberto Bergamaschi, Vincenzo Brescia Morra, Giancarlo Comi, Salvatore Cottone, Luigi M.E. Grimaldi, Giovanni Luigi Mancardi, Luca Massacesi, Ugo Nocentini, Marco Salvetti, Elio Scarpini, Patrizia Sola, Gioacchino Tedeschi, María Trojano, Mauro Zaffaroni, Stephan Frequin, Raymond Hupperts, Joep Killestein, Hans M. Schrijver, Ronald Van Dijl, Erik van Munster, Maciej Czarnecki, Wiesław Drozdowski, Waldemar Fryze, Hanka Hertmanowska, Jan Ilkowski, Anna Kamińska, Gabriela Kłodowska-Duda ほか 90 名 - The Lancet Neurology 2018 被引用: 337

  7. Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

    著者: Gavin Giovannoni, Per Soelberg Sørensen, Stuart D. Cook, Kottil Rammohan, Peter Rieckmann, Gıancarlo Comı, Fernando Dangond, Abidemi Adeniji, Patrick Vermersch - Multiple Sclerosis Journal 2017 被引用: 333

  8. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study

    著者: Elena H. Martínez‐Lapiscina, Sam Arnow, James A. Wilson, Shiv Saidha, Jana Lízrová Preiningerová, Timm Oberwahrenbrock, Alexander U. Brandt, Luís E. Pablo, Simone Guerrieri, Inés González‐Suarez, Olivier Outteryck, Ann‐Kristin Mueller, Phillip J. Albrecht, Wesley Chan, Sebastian Lukas, Lisanne J. Balk, Clare L. Fraser, Jette Lautrup Frederiksen, Jennifer Resto, Teresa C. Frohman, Christian Cordano, Irati Zubizarreta, Magí Andorrà, Bernardo Sánchez‐Dalmau, Albert Saiz, Robert Bermel, Alexander Klistorner, Axel Petzold, Sven Schippling, Fiona Costello, Orhan Aktaş, Patrick Vermersch, Celia Oreja‐Guevara, Gıancarlo Comı, Letizia Leocani, Elena García‐Martín, Friedemann Paul, Eva Havrdová, Elliot M. Frohman, Laura J. Balcer, Ari Green, Peter A. Calabresi, Pablo Villoslada - The Lancet Neurology 2016 被引用: 333

  9. Inhibition of CD40L with Frexalimab in Multiple Sclerosis

    著者: Patrick Vermersch, Cristina Granziera, Yang Mao‐Draayer, Gary Cutter, O. I. Kalbus, Ivan Staikov, Michal Dufek, Stéphane Saubadu, Raphaël Bejuit, Philippe Truffinet, Biljana Djukic, Erik Wallstroem, Gavin Giovannoni - New England Journal of Medicine 2024 被引用: 85

  10. Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria

    著者: Sven Schippling, LJ Balk, Fiona Costello, Philipp Albrecht, Laura J. Balcer, Peter A. Calabresi, Jette Lautrup Frederiksen, E. Frohman, A. J. Green, Alexander Klistorner, Olivier Outteryck, Friedemann Paul, GT Plant, Ghislaine L. Traber, Patrick Vermersch, Pablo Villoslada, Sebastián Wolf, Axel Petzold - Multiple Sclerosis Journal 2014 被引用: 305

  11. Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study

    著者: Friedemann Paul, Peter A. Calabresi, Frederik Barkhof, Ari Green, Randy H. Kardon, Jaume Sastre‐Garriga, Sven Schippling, Patrick Vermersch, Shiv Saidha, Bianca S. Gerendas, Ursula Schmidt‐Erfurth, Catherine Agoropoulou, Ying Zhang, Gustavo Seifer, Axel Petzold - Annals of Clinical and Translational Neurology 2021 被引用: 95

  12. Natural History of Multiple Sclerosis with Childhood Onset

    著者: Christel Renoux, Sandra Vukusic, Yann Mikaeloff, Gilles Edan, Michel Clanet, Bénédicte Dubois, Marc Debouverie, Bruno Brochet, Christine Lebrun‐Frénay, Jean Pelletier, Thibault Moreau, Catherine Lubetzki, Patrick Vermersch, E Roullet, Laurent Magy, Marc Tardieu, Samy Suissa, Christian Confavreux - New England Journal of Medicine 2007 被引用: 591

  13. Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome

    著者: Christine Lebrun‐Frénay, Aksel Sıva, Maria Pia Sormani, Cassandre Landes-Château, Lydiane Mondot, Francesca Bovis, Patrick Vermersch, Caroline Papeix, Éric Thouvenot, Pierre Labauge, Françoise Durand‐Dubief, Hüsnü Efendi, Emmanuelle Le Page, Murat Terzi, Nathalie Derache, Bertrand Bourre, Robert Hoepner, Rana Karabudak, de Sèze, Jonathan Ciron, Pierre Clavelou, Sandrine Wiertlewski, Ömer Faruk Turan, Nur Yucear, Mikaël Cohen, Christina Azevedo, Orhun H. Kantarci, Darin T. Okuda, Daniel Pelletier, TERIS Study Group, Pierre Branger, Mouloud Abrous, Hélène Zéphir, Julie Petit, Sandra Vukusic, Céline Gelet, Clarisse Carra‐Dallière, Xavier Ayrignac, Mélanie Russello, David Laplaud, Alina Gaultier, Fabienne Le Frère, Céline Callier, Cynthia Caillon, Eglantine Gueydan, Céline Louapre, Damien Galanaud, Aurelian Ungureanu, Sylvie Coudoin, Benjamin Hébant, Emmanuel Gerard, Christine Vimont, Damien Biotti, Fabrice Bonneville, Noellie Freitas, Taşkın Duman, Erhan Kilic, Melih Tütüncü, Uğur Uygunoğlu, Sena Destan, Sedat Şen, Christoph Friedli, Franca Wagner, Lea Weber, Annaig Tchoubar, Émilie Dumont, Asli Eryilmaz, Tanguy Roman, Christopher Pelletreau, Aurélie Grateau, Yanica Mathieu, Sarhan Yaïche, Felix Rintelen, Isabel Firmino, Aymeric De Chastenier, Amel Gheribenblidia, Burcu Zeydan - JAMA Neurology 2023 被引用: 89

  14. Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials

    著者: Xavier Montalbán, Patrick Vermersch, Douglas L. Arnold, Amit Bar-Or, Bruce Cree, Anne H. Cross, Eva Havrdová, Ludwig Kappos, Olaf Stüve, Heinz Wiendl, Jerry S. Wolinsky, Frank Dahlke, Claire Le Bolay, Li Shen Loo, Sathej Gopalakrishnan, Yann Hyvert, Andrija Javor, Hans Guehring, Nadia Tenenbaum, Davorka Tomic, Adriana Josefa Carra, Norma Haydee Deri, Jorge Gustavo Jose, Susana del Valle Liwacki, Carolina Natalia Mainella, Fatima Pagani, Guillermo Povedano, Alberto Rodriguez Alfici, Dario Raul Tavolini, Carlos Federico Buonanotte, Marcos Burgos, Juan Carlos Giugni, Juan Jose Martin Artesi, Juan Ignacio Rojas, Daniel Raul Zuin, Hugo Osvaldo Videla, Jorge Daniel Correale, Geraldine G. Luetic, Suzanne Hodgkinson, Jeannette Lechner-Scott, John Parratt, Noel Saines, Stephen Reddel, Tissa Wijeratne, Bruce Taylor, Florian Deisenhammer, Gerhard Traxler, Fritz Leutmezer, Peter Wipfler, Joerg R. Weber, Christian Lampl, Emmanuel Bartholome, Dominique Dive, Nele Glibert, Gaetano Perrotta, Vincent Pesch, Maarten Buyle, Bart Wijmeersch, Barbara Willekens, Edin Basagic, Enra Mehmedika Suljic, Inge Klupka-Sarić, Maya Danovska, Maria Dimitrova, Krasimir Genov, Alim Izmaylov, Radoslav Mavrov, Ivan Milanov, Valcho Naydenov, Penko Shotekov, Ivaylo Tarnev, Latchezar Traykov, Francois Emond, Daniel Selchen, Donald Rivest, Lisa Sabella, Ludivine Witkowski, Alexander Saveriano, Addinson Rene Bolano Solano, Cesar Augusto Franco Ruiz, Andrea Catalina Nassar Tobon, Carlos Alberto Navas Cardozo, Antonio Schlesenger, Javier Dario Triana, Osvaldo Elias Lara Sarabia, Luis Alfonso Zarco Montero, Jorge Andres Jimenez Arango, Silvio Basic, Marija Bosnjak Pasic, Silva Butkovic Soldo, Mario Habek, Spomenka Kidjemet-Piskac, Meri Matijaca, Vladimira Vuletic, Radek Ampapa, Michal Dufek, Marketa Grunermelova, Jan Mares, Alena Martinkova, Marek Peterka ほか 607 名 - The Lancet Neurology 2024 被引用: 72

  15. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging

    著者: Philip Scheltens, Frederik Barkhof, Didier Leys, Jean‐Pierre Pruvo, J. Nauta, Patrick Vermersch, M Steinling, Jaap Valk - Journal of the Neurological Sciences 1993 被引用: 928

  16. Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis

    著者: Patrick Vermersch, Luís Brieva, Robert J. Fox, Friedemann Paul, Lluís Ramió‐Torrentà, Matthias Schwab, Alain Moussy, Colin D. Mansfield, Olivier Hermine, Maciej Maciejowski, on behalf of the AB07002 Study Group, Nassima Hecham, Norma Deri, Jasminka Djelilović-Vranić, Ivan Milanov, Penko Shotekov, Gregg Blevins, J Girard, Yves Lapierre, William Camu, Giovanni Castelnovo, Pierre Clavelou, P. Hautecoeur, Martin Marziniak, Christoph Mayer, Patrick Oschmann, Gerd Reifschneider, I. Schoell, Björn Tackenberg, Florian Then Bergh, Ν. Fakas, Nikolaos Grigoriadis, D. Kalochristianakis, Dimos D. Mitsikostas, Anastasios Orologas, Antonios Tavernarakis, Thomas Thomaidis, Krisztina Kovács, K Mátyás, Pálma Piros, Mária Sátori, K.J.S. Anand, Alexander L. Shifrin, Krzysztof Banaszkiewicz, Robert Bonek, M. Chahwan, M. Czernichowska - Kotiuszko, Lidia Darda-Ledzion, J. D. Wojcik, M Dziki, Ewa Krzystanek, Marianna Kulka, Paweł Lisewski, Marcin Ratajczak, Andrzej Szczudlik, Jarosław Szczygieł, Małgorzata Pańczyk-Tomaszewska, Jacek Wójcik, Daniel Zielonka, M. Chiru, Swaroopa Deme, S Mănescu, S.A. Nica, Christian Popescu, Szabolcs Szatmári, A. L. Fedyanin, N A Malkova, D.V. Popov, Л. И. Волкова, Vorob'eva Ov, M Brozman, Andrea Cimprichová, P. Cuchran, Ladislav Gurcik, Georgi Krastev, I. Lisá, M. Nyeky, J. Poljaková, Peter Turčáni, Adaani Frost, Josef G. Heckmann, Eduardo Agüera, Francisco Coret, Antonio Escartín, Victoria Fernández, JR. Ara Callizo, Greg S. Martin, José Rodríguez, M. Martinez Gines, Daniel Muñoz, Javier Olascoaga, José M. Prieto, Cristina Ramo‐Tello, Samir Belal, S. Ben Ammou, Mahbouba Frih-Ayed, Riadh Gouider, Chokri Mhiri, Ridha Mrissa, Alla Cherkez ほか 21 名 - Neurology Neuroimmunology & Neuroinflammation 2022 被引用: 67

  17. Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome

    著者: Christine Lebrun‐Frénay, Fabien Rollot, Lydiane Mondot, Hélène Zéphir, Céline Louapre, Emmanuelle Le Page, Françoise Durand‐Dubief, Pierre Labauge, Caroline Bensa, Éric Thouvenot, David Laplaud, de Sèze, Jonathan Ciron, Bertrand Bourre, Philippe Cabre, Olivier Casez, Aurélie Ruet, Guillaume Mathey, Éric Berger, Thibault Moreau, A. Al Khedr, Nathalie Derache, Pierre Clavelou, Anne‐Marie Guennoc, Alain Créange, Jean‐Philippe Neau, Ayman Tourbah, Jean‐Philippe Camdessanché, Adil Maarouf, Céline Callier, Patrick Vermersch, Orhun H. Kantarci, Aksel Sıva, Christina Azevedo, Naila Makhani, Mikaël Cohen, Daniel Pelletier, Darin T. Okuda, Sandra Vukusic, RISC, SFSEP, and OFSEP Investigators, Orhun H. Kantarci, Aksel Sıva, Daniel Pelletier, Darin T. Okuda, Christina Azevedo, Naila Makhani, Fataï Radji, Nathalie Morel, Deborah Grosset-Jeannin, Aurelian Ungureanu, L Boyer, Laurent Suchet, Zyad Elias, Christine Lebrun‐Frénay, Mikaël Cohen, Lydiane Mondot, Éric Thouvenot, Jonathan Ciron, Françoise Durand‐Dubief, Bruno Brochet, Aurélie Ruet, Jean‐Christophe Ouallet, Gilles Defer, Pierre Branger, Nathalie Derache, Pierre Clavelou, Frédéric Taithe, Adullatif Alkhedr, Agnès Fromont, Thibault Moreau, Ayman Tourbah, Olivier Casez, Éric Berger, Hélène Zéphir, Olivier Outteryck, Patrick Vermersch, Patrick Hautecoeur, G. Androdias, Iuliana Ionescu, Jean Pelletier, Bertrand Audoin, Adil Maarouf, Xavier Ayrignac, Clarisse Carra‐Dallière, Pierre Labauge, Marc Debouverie, Guillaume Mathey, Philippe Cabre, David Laplaud, Sandrine Wiertlevski, Saskia Bresch, Giovanni Castelnovo, Caroline Papeix, Céline Louapre, Élisabeth Maillart, Catherine Lubetzki, Bruno Stankoff, Bertrand Fontaine, C. Giannesini, Olivier Heinzleff ほか 70 名 - JAMA Network Open 2021 被引用: 86

  18. Effect of Dimethyl Fumarate vs Interferon β-1a in Patients With Pediatric-Onset Multiple Sclerosis

    著者: Patrick Vermersch, Matthew Scaramozza, Seth Levin, Raed Alroughani, Kumaran Deiva, Carlo Pozzilli, Jennifer Lyons, Oksana Mokliatchouk, Joe Pultz, Fatou N’Dure, Shifang Liu, Runda Badwan, Filipe Branco, Valencia Hood-Humphrey, Nathalie Franchimont, Jerome Hanna, Amir‐Hadi Maghzi - JAMA Network Open 2022 被引用: 53

  19. Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis

    著者: Gıancarlo Comı, Stuart D. Cook, Gavin Giovannoni, Peter Rieckmann, Per Soelberg Sørensen, Patrick Vermersch, Andrew Galazka, Axel Nolting, Christine Hicking, Fernando Dangond - Multiple Sclerosis and Related Disorders 2019 被引用: 142

  20. Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event

    著者: Darin T. Okuda, Aksel Sıva, Orhun H. Kantarci, Matilde Inglese, Ilana Katz, Melih Tütüncü, B. Mark Keegan, Stacy Donlon, Le H. Hua, Ángela Vidal‐Jordana, Xavier Montalbán, Àlex Rovira, Mar Tintoré, Maria Pia Amato, Bruno Brochet, J. de Sèze, David Brassat, Patrick Vermersch, Nicola De Stefano, Maria Pia Sormani, Daniel Pelletier, Christine Lebrun‐Frénay - PLoS ONE 2014 被引用: 332

  21. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease

    著者: André Delacourte, Jean‐Philippe David, Nicolas Sergeant, Luc Buée, A. Wattez, Patrick Vermersch, Farida Ghozali, Catherine Fallet‐Bianco, Florence Pasquier, Florence Lebert, H Petit, Claude Di Menza - Neurology 1999 被引用: 809

  22. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group

    著者: Peter Rieckmann, Diego Centonze, Irina Elovaara, Gavin Giovannoni, Eva Havrdová, Jürg Kesselring, Gisela Kobelt, Dawn Langdon, Sarah A. Morrow, Celia Oreja‐Guevara, Sven Schippling, Christoph Thalheim, Heidi Thompson, Patrick Vermersch, Karen Aston, Birgit Bauer, Christy Demory, Maria Paz Giambastiani, Jana Hlaváčová, Jocelyne Nouvet-Gire, George Pepper, Maija Pontaga, Emma Rogan, Chrystal Rogalski, Pieter van Galen, Ali-Frédéric Ben-Amor - Multiple Sclerosis and Related Disorders 2017 被引用: 140

  23. Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis

    著者: Robert J. Fox, Amit Bar-Or, Anthony Traboulsee, Celia Oreja‐Guevara, Gavin Giovannoni, Patrick Vermersch, Sana Syed, Ye Li, Wendy Vargas, Timothy J. Turner, Erik Wallstroem, Daniel S. Reich - New England Journal of Medicine 2025 被引用: 111

  24. Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets

    著者: Heinz Wiendl, Klaus Schmierer, Suzanne Hodgkinson, Tobias Derfuß, Andrew Chan, Finn Sellebjerg, Anat Achiron, Xavier Montalbán, Alexandre Prat, Nicola De Stefano, Frederik Barkhof, Letizia Leocani, Patrick Vermersch, Anita Chudecka, Claire Mwape, Kristina Holmberg, Ursula Boschert, Sanjeev Roy - Neurology Neuroimmunology & Neuroinflammation 2022 被引用: 41